NSB
Click for more information
2.56% 3.8¢ neuroscientific biopharmaceuticals ltd

Ann: NSB files new patent, page-4

  1. CHRIS77
    203 Posts.
    lightbulb Created with Sketch. 19
    clock Created with Sketch.
    05/12/22
    09:24
    Post #: 65147503
    You would think that the owner of copaxone would ( since Copaxone its not very effective by itself) would be eyeing NSB off with its extremely low market cap and massive potential. Maybe at least take a huge position with a potential take over after some further studies.
    NSB Price at posting: 15.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
NEWS Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
(20min delay)
Last
3.8¢ 		Change
-0.001(2.56%) 		Mkt cap ! $5.494M
Open High Low Value Volume
3.7¢ 3.8¢ 3.7¢ $3.656K 97.26K

Buyers (Bids)

No. Vol. Price($)
1 7 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 25000 1
View Market Depth
Last trade - 14.31pm 03/07/2024 (20 minute delay) ?
NSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.